We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$130M
AUM Growth
-$94.8M
Cap. Flow
-$92.4M
Cap. Flow %
-70.88%
Top 10 Hldgs %
76.28%
Holding
62
New
12
Increased
4
Reduced
12
Closed
32

Sector Composition

Rank Sector Weight
1 Healthcare 52.71%
2 Materials 19.6%
3 Industrials 11.26%
4 Communication Services 4.3%
5 Technology 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALC icon
1
Alcon
ALC
$34.2B
$19.9M 15.25%
+340,690
New +$20.4M
BMY icon
2
Bristol-Myers Squibb
BMY
$123B
$10.3M 7.9%
202,857
-32,613
-14% -$1.53M
ASH icon
3
Ashland
ASH
$3.1B
$9.68M 7.43%
125,645
-107,634
-46% -$8.17M
CELG
4
DELISTED
Celgene Corp
CELG
$9.51M 7.3%
95,800
-21,600
-18% -$2.05M
MDSO
5
DELISTED
Medidata Solutions, Inc.
MDSO
$9.35M 7.17%
102,140
+39,884
+64% +$3.64M
QGEN icon
6
Qiagen
QGEN
$8.35B
$9.24M 7.09%
266,133
-27,840
-9% -$1.07M
DD icon
7
DuPont de Nemours
DD
$18.3B
$8.92M 6.84%
99,619
-130,388
-57% -$11.5M
AGN
8
DELISTED
Allergan plc
AGN
$8.15M 6.25%
48,402
+28,402
+142% +$4.63M
ZAYO
9
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$7.77M 5.96%
229,221
+159,935
+231% +$5.39M
VSM
10
DELISTED
Versum Materials, Inc.
VSM
$6.61M 5.07%
124,902
+44,902
+56% +$2.33M
T icon
11
AT&T
T
$153B
$4.66M 3.57%
162,912
-200,024
-55% -$5.3M
AMGN icon
12
Amgen
AMGN
$197B
$4.65M 3.57%
+24,008
New +$4.61M
CBM
13
DELISTED
Cambrex Corporation
CBM
$3.88M 2.97%
+65,127
New +$3.49M
OMN
14
DELISTED
OMNOVA Solutions Inc.
OMN
$3.46M 2.66%
+343,761
New +$3.41M
CY
15
DELISTED
Cypress Semiconductor
CY
$2.92M 2.24%
125,000
MLNX
16
DELISTED
Mellanox Technologies, Ltd.
MLNX
$2.12M 1.63%
19,348
-25,652
-57% -$2.83M
GHDX
17
DELISTED
Genomic Health, Inc.
GHDX
$2.03M 1.56%
+30,000
New +$2.06M
WAIR
18
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$1.87M 1.43%
+169,709
New +$1.84M
TAK icon
19
Takeda Pharmaceutical
TAK
$54.4B
$1.08M 0.83%
62,638
-217,362
-78% -$3.76M
PACB icon
20
Pacific Biosciences
PACB
$422M
$1.03M 0.79%
198,743
-200,000
-50% -$1.12M
TIMB icon
21
TIM SA
TIMB
$10.6B
$946K 0.73%
65,902
-362,647
-85% -$5.48M
FTSV
22
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$598K 0.46%
93,182
-31,818
-25% -$261K
CTMX icon
23
CytomX Therapeutics
CTMX
$766M
$399K 0.31%
54,065
-52,935
-49% -$522K
FTI icon
24
TechnipFMC
FTI
$28.7B
$377K 0.29%
+21,089
New +$393K
ONCE
25
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$218K 0.17%
2,253

Similar funds

Exane Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Exane Asset Management held 62 positions worth $130M, down 42% from $225M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Exane Asset Management withdrew a net $92.4M in Q3 2019, closing 32 positions and reducing 12 holdings. Its most notable exit was Red Hat Inc, an estimated $12.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 30% a quarter earlier, followed by Materials and Industrials.

Against the trend, Exane Asset Management opened a new position in Alcon worth $19.9M.

  • Exane Asset Management's largest Q3 2019 buy was Alcon: 340,690 shares worth $19.9M.
  • Exane Asset Management added most to Zayo Group Holdings, Inc. in Q3 2019, an estimated $5.39M increase.
  • Exane Asset Management's biggest Q3 2019 reduction was DuPont de Nemours, cutting an estimated $11.5M.
  • Exane Asset Management fully exited Red Hat Inc in Q3 2019, selling an estimated $12.5M.
  • Exane Asset Management's ten largest holdings make up 76% of its $130M portfolio in Q3 2019.
  • Exane Asset Management opened 12 new positions and closed 32 in Q3 2019.
  • Exane Asset Management's portfolio value fell 42% quarter-over-quarter to $130M.

Based on Exane Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.